CELLULAR MECHANISM OF ACTION OF LOOP DIURETICS - IMPLICATIONS FOR DRUG EFFECTIVENESS AND ADVERSE-EFFECTS

被引：25

作者：

FEIG, PU ^{[1
]}

机构：

[1] UNIV CONNECTICUT,SCH MED,DEPT MED,FARMINGTON,CT 06032

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 1986年 / 57卷 / 02期

关键词：

D O I：

10.1016/0002-9149(86)91001-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：A14 / A19

页数：6

共 57 条

[1] INTRAMUSCULAR BUMETANIDE AND FUROSEMIDE IN CONGESTIVE HEART-FAILURE [J].

ABRAMS, J .

JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 21 (11-1) :673-679

[2]

ALTON JF, 1981, BIOCH BIOPHYS ACTA, V646, P389

[3] PHARMACOKINETICS-PHARMACODYNAMICS OF FUROSEMIDE IN MAN - REVIEW [J].

BENET, LZ .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1979, 7 (01) :1-27

[4] ELECTROLYTE EXCRETION PATTERNS - INTRAVENOUS AND ORAL DOSES OF BUMETANIDE COMPARED TO FUROSEMIDE [J].

BRATER, DC ;

FOX, WR ;

CHENNAVASIN, P .

JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 21 (11-1) :599-603

[5] ABSORPTION AND DISPOSITION OF FUROSEMIDE IN CONGESTIVE HEART-FAILURE [J].

BRATER, DC ;

SEIWELL, R ;

ANDERSON, S ;

BURDETTE, A ;

DEHMER, GJ ;

CHENNAVASIN, P .

KIDNEY INTERNATIONAL, 1982, 22 (02) :171-176

[6] FUROSEMIDE IN PATIENTS WITH HEART-FAILURE - SHIFT IN DOSE-RESPONSE CURVES [J].

BRATER, DC ;

CHENNAVASIN, P ;

SEIWELL, R ;

BECK, J .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (02) :182-186

[7] BUMETANIDE AND FUROSEMIDE [J].

BRATER, DC ;

CHENNAVASIN, P ;

DAY, B ;

BURDETTE, A ;

ANDERSON, S .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 34 (02) :207-213

[8] BUMETANIDE AND FUROSEMIDE IN HEART-FAILURE [J].

BRATER, DC ;

DAY, B ;

BURDETTE, A ;

ANDERSON, S .

KIDNEY INTERNATIONAL, 1984, 26 (02) :183-189

[9] RENAL ISCHEMIA - A NEW PERSPECTIVE [J].

BREZIS, M ;

ROSEN, S ;

SILVA, P ;

EPSTEIN, FH .

KIDNEY INTERNATIONAL, 1984, 26 (04) :375-383

[10]

BROWN RD, 1979, TOXICOL APPL PHARM, V48, P157, DOI 10.1016/S0041-008X(79)80018-6

← 1 2 3 4 5 6 →